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The methicillin-resistant Staphylococcus aureus (MRSA) is one of the major
causes of a variety of infections in hospitals and the community. One of the most
prominent changes in the MRSA epidemiology is the emergence of livestock-
associated MRSA (LA-MRSA) strains in the human population. The aim of this
study was to follow the MRSA epidemiology in a large teaching hospital during an
8-year time period (2006–2013). Altogether 519 MRSA, cultured from screening or
clinical samples, were distributed into 77 spa types, of which three (t003 and t001,
associated with CC5; and t015; associated with CC45) were the most common.
LA-MRSA-associated spa types (t011, t034, t108, t899; associated with CC398)
started to emerge in the year 2009 and continued to be found annually at a frequency
from 3.9% to 12.7% of all MRSA strains examined. Only 6 of 27 LA-MRSA strains
were associated with infections.
Keywords: spa typing, LA-MRSA, Staphylococcus aureus, animals,
colonization
Introduction
The methicillin-resistant Staphylococcus aureus (MRSA) is one of the most
important multidrug resistant microorganisms and primarily causes healthcare-
associated (HA-MRSA) infections [1, 2]. During the past two decades, MRSAwas
also increasingly reported in the community and this type was designated a
commmunity-associated MRSA (CA-MRSA). The CA-MRSA and HA-MRSA
could be differentiated epidemiologically by association with nosocomial settings,
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as well as the time of onset in the hospital. They could also be differentiated
pheno- and genotypically by attribution to clonal lineages (complexes), the type of
SCCmec element, antibiotic resistance patterns, and the virulence potential [3, 4].
However, the distinction between both groups is disappearing [3]. The CA-MRSA
is acquiring additional antibiotic resistances and both types are currently circulat-
ing in hospitals as well as in the community. Some successful clones have spread
worldwide [5–7]. Since 2005, a group of MRSA associated with farm animals,
termed as livestock-associated MRSA (LA-MRSA), started to emerge in the
human population [8, 9]. The most common LA-MRSA group is ST398 with a
large number of different spa types [7, 8, 10, 11]. Although LA-MRSA represents
less than 10% of strains isolated from humans in the majority of countries, it is
important to follow the national and local rates in order to adapt patient screening
if necessary [11].
In Slovenia, the MRSA is well controlled and the MRSA colonization rate is
used as a quality indicator [12, 13]. The hospitals have issued guidelines for the
prevention of MRSA healthcare-associated transmission, including hand hygiene,
which is the most important infection control measure, patient isolation, and
surveillance of patients at risk [14]. However, despite good hospital controls, at
present, a detailed MRSA epidemiology in Slovenia is less than thoroughly
investigated, as the focus is mainly on the CA-MRSA [15–17]. Newly described
mecC-positive isolates have been found in a large collection of 395 CA-MRSA,
isolated nationwide from 2006 to 2013 [18]. In the same collection, a subset of
MRSA isolated in 2010 were spa- and MLST-typed, and tested for presence of
toxin genes [19]. Of 151 isolates, 9.9% belonged to ST398, representing the first
report of LA-MRSA strains in Slovenia. Slovenian laboratories also participated in
large international studies on S. aureus bloodstream infections [1, 20], MRSA in
intensive care units (ICUs) [21], and an ECDC cross-sectional study on LA-
MRSA for the year 2013 [11].
In this context, the aim of this study was to analyze the epidemiology
of MRSA spa types in a single large teaching hospital during an extended
(8-year) time interval, and to determine the possible presence and proportion of
LA-MRSA.
Materials and Methods
Hospital setting
The University Clinical Centre Maribor (UCCM) is a tertiary teaching
hospital, located in the North–East region of Slovenia, serving a population of
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400,000. It has 1,300 beds with ca. 55,000 discharges (364,000 patient days)
per year including the study period. The hospital had an active MRSA surveillance
since 1999 and patients with at least one of the following risk factors are included
in the screening: previous hospitalization within the last 12 months, transfer from
another hospital or from a long-term care facility, previously known colonization
with MRSA, patients with chronic wounds, all patient in critical care units,
patients undergoing clean elective and implant surgery, patients on peritoneal
dialysis, patients with more than 24 h room contact with a patient who was a
confirmed as MRSA carrier, and healthcare workers at the wards with proven
MRSA cases at the time of an epidemic.
Ethics
Ethical approval for this study was obtained from the National Medical Ethic
Committee (no. KME84/08/12).
Isolation and characterization of MRSA
For the strain selection, isolation, and characterization, we followed the
methods of Kotnik-Kevorkijan et al. [22]. S. aureus cultivated from clinically
relevant samples were recognized as MRSA because of the resistance to
cefoxitin, and were subsequently confirmed with mecA testing. For surveillance
samples, the conventional culture media, including MRSA-screening plates
(CHROMID® MRSA, bioMerieux, Marcy-l’Etoile, France) and trypticase soy
broth containing NaCl, were used. MRSA strains were confirmed by PCR
amplification of the mecA gene by a modification of previously published
methods [23, 24]. An in-house method is established and is based on amplifica-
tion of three different PCR products; two are S. aureus-specific and one targets
mecA gene. The mecC testing was introduced in the second half of the year 2013
for strains that were resistant to cefoxitine and negative for mecA. No strains
fulfilling these criteria were detected within the study interval. All isolates were
frozen at −70 °C until further characterization. Only the first isolate of each
patient was stored.
Antimicrobial susceptibility testing
Susceptibility testing, using a standard selection of antibiotics for
S. aureus, was performed by disk diffusion according to the CLSI Performance
Standards for Antimicrobial Susceptibility Testing (CLSI document M100;
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https://clsi.org/standards/products/microbiology/documents/m100/). The antibiotics
tested were tetracycline, clindamycin, erythromycin, ciprofloxacin, gentamycin,
tobramycin, mupirocin, linezolid, trimethoprim–sulfamethoxazole, teicoplanin,
vancomycin, and netilmicin. Since 2011, the susceptibility to vancomycin has
been assessed by E-test.
Strain selection and spa typing
The MRSA, which were typed, were isolated between January 2006 and
December 2013 from either surveillance or clinical samples. Only the first isolate
of each patient was included in the analysis.
The isolates were thawed and cultured on blood agar. After DNA isolation
using the QIAamp DNA Kit (QIAgen, Venlo, Netherlands), the spa region was
amplified using primers and conditions as described previously [25] and sequenced
by a commercial service (MWG, Martinsried, Germany). The spa types were
assigned using the Ridom StaphType software (Ridom GmbH, Würzburg, Ger-
many) [25]. The Based Upon Repeat Pattern (BURP) algorithm of Ridom Staph-
Type software was used to analyze the similarity of spa types and the grouping into
clusters using the conditions described in the study of Mellmann et al. [26].
Results
Overall, 519 MRSA isolates from UCCM were spa typed between the
years 2006 and 2013. The cultures were mostly obtained from surveillance
swabs (nose, throat, skin, or wound) or, in rare cases, from other surveillance
samples (urine or feces) and from patients with developed infections (blood
culture, urine sample, swabs from wound, eye, ear, and oral mucosa). Altogether
77 spa types were found (Table I), three of which (t003, t001, and t015) were
represented by more than 50 isolates each. Three further spa types (t041,
t091, and t728) were also frequently isolated during this time period, whereas
40 spa types were represented only by a single isolate (2 LA-MRSA and
38 non-LA-MRSA spa types; Table I). Using the BURP algorithm, three large
and several small clusters were obtained (Figure 1). Twelve spa types were
singletons (t151, t316, t334, t791, t899, t1048, t1179, t1321, t3824, t4230,
t4365, and t14168) and additional six were excluded from the analysis due to the
low number of repeats (t026, t288, t390, t458, t808, and t1040).
The spa types associated with the LA-MRSA (t011, t034, t108, and t899)
started to emerge in the year 2009 (Table I). These types represented 5.2%
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Table I. Overview of spa types detected in a single hospital in 8-year period
spa type CCa 2006 2007 2008 2009 2010 2011 2012 2013 Σ
t003 CC5 6 8 6 28 16 19 44 24 151
t001 CC5 38 20 6 4 1 – – – 69
t015 CC45 – 2 2 12 15 8 7 6 52
t041 CC5 2 – 12 6 2 3 1 – 26
t091 CC7 – 11 1 2 3 – 1 1 19
t728 nd – 2 – 3 6 2 2 4 19
t011 CC398 – – – 3 6 1 1 6 17
t034 CC398 – – – 2 – 1 2 3 8
t108 CC398 – – – – 1 – – – 1
t899 CC398 – – – – – 1 – – 1
t002 CC5 – 2 – 3 2 1 – 2 10
t005 CC22 1 2 – 1 3 – 2 1 10
t288 nd 8 1 – – – – – – 9
t006 nd – 1 1 3 1 – – – 6
t355 CC152 1 – – 1 2 1 – 1 6
t008 CC8 – – – 1 1 2 1 – 5
t026 nd – – – 1 1 – 2 1 5
t127 CC1 – – – 1 2 2 – – 5
t331 nd – – – – – 2 2 1 5
t808 nd – – – – – 2 1 2 5
t5605 nd – – – – – 4 – 1 5
t201 nd 1 1 – 2 – – – – 4
t3255 nd – 4 – – – – – – 4
t3824 nd – 2 – – 1 – – 1 4
t030 ST239 3 – – – – – – – 3
t032 CC22 – 3 – – – – – – 3
t037 ST239 – – 2 – – – 1 – 3
t116 CC45 – – – – – 1 2 – 3
t919 nd – 1 – 1 – 1 – – 3
10 typesb 1 1 2 2 1 3 2 8 20
38 typesb 3 6 1 4 4 6 5 9 38
No. of typed
MRSA
strains
64 67 33 80 68 60 76 71 519
LA-MRSA 0 0 0 5 7 3 3 9 27
Note: spa types are grouped into most prevalent types, LA-MRSA types, types with up to three isolates, and
sporadic types (one or two isolates).
aCC deduced from spa type (based on data at Ridom server and Ref. [27]).
bspa types present only by two strains (10) or by a single strain (38): t014, t020, t031, t044, t050, t062,
t073, t102, t122, t133, t151, t310, t316, t334, t359, t360, t390, t449, t458, t542, t548, t550, t595, t685,
t688, t709, t791, t830, t950, t1040, t1048, t1179, t1321, t2986, t3432, t3445, t4072, t4230, t4272,
t4365, t5047, t5933, t7736, t8014, t10458, t10459, t14167, and t14168.
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(27/591) of all characterized strains, and ranged from 3.9% to 12.7% of all isolates
within an individual year. Only six of 27 LA-MRSA strains were associated with
infections (Table II).
Although antibiotic resistance was routinely tested during the MRSA
isolation, data are shown only for the LA-MRSA (Table III). All strains were
resistant to tetracycline alone or together with other antibiotics. However, all
strains were susceptible to mupirocin, linezolid, trimethoprim–sulfamethoxazole,
teicoplanin, vancomycin, and netilmicin.
Figure 1. BURP clustering of spa types found in the hospital. The spa type with the highest
founder-score is defined as the founder of the cluster (blue color); several spa types could have
identically high founder-scores. The spa types with the second highest founder-score (subfounders)
are marked with yellow
Table II. Summary of clinically relevant LA-MRSA strains showing the patient age and gender and of
clinical presentations
Gender
Age
(years)
Clinical diagnosis related
to LA-MRSA
MRSA isolation
year spa type
Female 44 Pneumonia 2010 t108
Female 53 Otitis media 2011 t011
Male 52 Osteitis 2012 t011
Male 53 Pneumonia 2012 t034
Female 76 Conjunctivitis 2013 t011
Female 71 Stomatitis 2013 t011
Note: MRSA: methicillin-resistant Staphylococcus aureus; LA-MRSA: livestock-associated MRSA.
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Discussion
The reported rates for UCCM between 1998 and 2007 ranged from 53 to 114
patients colonized or infected with MRSA, and MRSA represented from 4.5% to
10% of all S. aureus isolates [22]. Information for the year 2008 is not available,
but from 2009 to 2013, the number of MRSA patients and the percentage of
MRSA among S. aureus isolates are comparable to the previous study (Table IV).
The spa types found in this study are associated with all main globally
distributed clonal complexes (CC5, CC8, CC22, and CC45) except CC30 (Table I)
[27]. Some spa types are associated with the clonal complex CC152, reported from
West European countries and previously suggested to be present in the Balkan
region [35]. Two spa types, associated with ST239, were also found in Asia
[35, 36]. CC398 was continuously present since the year 2009. The three globally
most widespread spa types (t002, t008, and t037) [28] were found, but in low
proportions.
Table III. Antibiotic resistances in strains belonging to LA-MRSA-associated spa types isolated from
surveillance or clinical samples (indicated by “infection”) in a single hospital from the year 2009 to 2013
Resistance
spa types (number of strains
from surveillance samples)
spa types (number of strains
from clinical samples)
Tetracycline t011 (7) and t034 (2) t011 (2)
Tetracycline and chloramphenicol t011 (1) t011 (1) and t108 (1)
Tetracycline and ciprofloxacin t011 (2) t899 (1)
Tetracycline, clindamycin, and
erythromycin
t011 (2) and t034 (4) –
Tetracycline, clindamycin,
erythromycin, and ciprofloxacin
– t034 (1)
Tetracycline, clindamycin,
erythromycin, gentamycin, and
tobramycin
t011 (2) –
Note: LA-MRSA: livestock-associated MRSA.
Table IV. Proportion of patients infected or colonized with MRSA during 5 out of 8 years of the
study interval
2009 2010 2011 2012 2013
All patients with MRSA 95 86 72 94 96
Infections with MRSA 7 (7.4%) 4 (4.6%) 1 (1.4%) 12 (12.8%) 5 (5.2%)
All patients with S. aureus 1,121 1,072 1,123 1,070 1,062
Percentage of MRSA among S. aureus 8.4 8.2 6.4 8.7 9.0
Number of days in bed 390,366 385,207 381,832 353,628 351,719
Number of discharges 61,218 62,689 60,535 52,497 56,752
Note: MRSA: methicillin-resistant Staphylococcus aureus.
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Some of the most common spa types found (e.g., t001, t003, and t041) are
frequently detected in several countries in Europe and worldwide. Type t001,
which was predominant at the beginning of the study period, was previously
reported for single Slovenian strain, isolated in 1999, and was also found in strains
isolated from Poland and Germany during the same time period [29]. Similar to
this study, t001 and t041 were among the predominant types reported from
hospitals in Croatia, Bosnia and Herzegovina, and Serbia [30, 31]. Types t001,
t041, and t003 were also commonly found in ICUs during the MOSAR study
(2008–2011) in Slovenia, as well as in Italy, Greece, and Luxemburg [21].
Type t003, which replaced t001 at UCCM over time (Table I), is the second
most common spa type in the Ridom server database (http://spa.ridom.de/
frequencies.shtml). This spa type was also common in clinical and surveillance
MRSA strains in one of the Canadian provinces [6], the second most
commonMRSA type found in the second European study on S. aureus bloodstream
infections [20], and the most commonly isolated MRSA from cases of bacteremia in
a large German federal state [32]. In Germany, type t003 also represented 64.3%
of all MRSA strains in residents of long-term care facilities [33]. The high proportion
of t003 strains at UCCM also appeared to have at least some relation to the
hospitalization of residents from nursing homes for the elderly (data not shown).
Of the two other frequently isolated spa types, t015 was also very common
in a previous national study, while t728 was limited only to UCCM [19].
Reports of LA-MRSA incidence vary considerably, depending on the
country and patient population. For example, a European surveillance in 2007
reported a LA-MRSA frequency ranging from 0% to 4.7%, with the exception of
the Netherlands (with 11. 9% in the national reference laboratory and 25% in a
single local laboratory) [8]. Ireland has reported low LA-MRSA levels (0.05%)
during a time period of 2010–2014 [34]. Characterization of more than 2500
MRSA isolates from an Austrian region close to UCCM found CC398 strains
represented 11.11% of isolates in 2007 and 8.17% in 2012 [35]. A study across
27 European countries has identified an overall proportion of 3.9% of LA-MRSA,
but in five countries (including Slovenia), the proportion was higher than 10%
[11]. The proportion of 3.9%–12.7% of LA-MRSA isolates within an individual
year correlates well with national data reported for presumptive CA-MRSA
analyzed in 2010 (9.9%; [19]).
As observed by others [21, 36, 37], the LA-MRSA was mostly isolated from
surveillance cultures and rarely caused disease in the studied hospital.
Pigs and cattle are considered the main reservoir for the LA-MRSA, and
people having professional contact with farm animals or living at industrial farms
are considered to have increased risk for colonization [9]. As the study was carried
out retrospectively, no further epidemiological data on possible animal contact are
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available, but a high proportion of LA-MRSA is consistent with the location of
UCCM in the more agriculturally oriented North–East region of Slovenia.
In summary, we found a broad diversity among MRSA strains in UCCM,
with the predominance of spa types associated with CC5 and CC45. LA-MRSA
represented up to 12.7% of all MRSA and started to emerge in the year 2009.
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